Thomas Woiwode Insider Trading $ADVM Adverum Biotechnologies, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas Woiwode.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas Woiwode. Thomas Woiwode is Director in Adverum Biotechnologies, Inc. ($AAVL) and Director in Audentes Therapeutics, Inc. ($BOLD) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Gritstone Oncology, Inc. ($GRTS) and Director in Passage BIO, Inc. ($PASG) and Director in Aligos Therapeutics, Inc. ($ALGS).
Thomas Woiwode in Adverum Biotechnologies, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Thomas Woiwode: Director
Holdings: 18,822 shares
Latest Transaction: May 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Thomas Woiwode in Adverum Biotechnologies, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADVM, ALGS, BOLD, CRSP, GRTS, PASG
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | ADVM | Adverum Biotechnol ... | Woiwode Thomas | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| Dec 16 2020 | ADVM | Adverum Biotechnol ... | Woiwode Thomas | Director | Buy | J | 0.00 | 12,783 | 0 | 18,822 | 6 K to 18.8 K (+211.67 %) |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Woiwode Thomas | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Aug 02 2019 | ADVM | Adverum Biotechnol ... | Woiwode Thomas | Director | Option Exercise | A | 13.41 | 45,000 | 603,450 | 45,000 | |
| Jun 15 2018 | ADVM | Adverum Biotechnol ... | Woiwode Thomas | Director | Option Exercise | A | 6.25 | 35,000 | 218,750 | 35,000 | |
| Jun 14 2017 | ADVM | Adverum Biotechnol ... | Woiwode Thomas | Director | Option Exercise | A | 2.75 | 33,602 | 92,406 | 33,602 | |
| Jun 14 2017 | ADVM | Adverum Biotechnol ... | Woiwode Thomas | Director | Grant | A | 0.00 | 22,727 | 0 | 70,380 | 47.7 K to 70.4 K (+47.69 %) |
| May 01 2017 | ADVM | Adverum Biotechnol ... | Woiwode Thomas | Director | Grant | A | 0.00 | 2,223 | 0 | 47,653 | 45.4 K to 47.7 K (+4.89 %) |
| Apr 03 2017 | ADVM | Adverum Biotechnol ... | Woiwode Thomas | Director | Grant | A | 0.00 | 3,704 | 0 | 45,430 | 41.7 K to 45.4 K (+8.88 %) |
| Mar 02 2017 | AAVL | Adverum Biotechnol ... | Woiwode Thomas | Director | Grant | A | 0.00 | 3,774 | 0 | 41,726 | 38 K to 41.7 K (+9.94 %) |
| Feb 02 2017 | AAVL | Adverum Biotechnol ... | Woiwode Thomas | Director | Grant | A | 0.00 | 3,449 | 0 | 37,952 | 34.5 K to 38 K (+10.00 %) |
| Jan 03 2017 | AAVL | Adverum Biotechnol ... | Woiwode Thomas | Director | Grant | A | 0.00 | 3,449 | 0 | 34,503 | 31.1 K to 34.5 K (+11.11 %) |
| Dec 01 2016 | AAVL | Adverum Biotechnol ... | Woiwode Thomas | Director | Grant | A | 0.00 | 3,509 | 0 | 31,054 | 27.5 K to 31.1 K (+12.74 %) |
| Nov 01 2016 | AAVL | Adverum Biotechnol ... | Woiwode Thomas | Director | Grant | A | 0.00 | 3,390 | 0 | 27,545 | 24.2 K to 27.5 K (+14.03 %) |
| Jul 01 2016 | AAVL | Adverum Biotechnol ... | Woiwode Thomas | Director | Option Exercise | A | 4.14 | 44,248 | 183,187 | 44,248 | |
| Jul 01 2016 | AAVL | Adverum Biotechnol ... | Woiwode Thomas | Director | Grant | A | 0.00 | 24,155 | 0 | 24,155 | 0 to 24.2 K |
Page: 1